The First Affiliated Hospital of Bengbu Medical College
Welcome,         Profile    Billing    Logout  
 4 Trials 
13 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
xie, jing
CRAD-001-03, NCT05295173: A Study of r-PA Treating Patients With Acute Ischemic Stroke（RAISE）

Completed
3
1412
RoW
Injection of recombinant human tissue plasminogen kinase derivatives, Reteplase, brand name: Ruitongli, r-PA, Recombinant human tissue plasminogen activator, Alteplase, brand name: Actilyse, rt-PA
Angde Biotech Pharmaceutical Co., Ltd., Beijing Tiantan Hospital
Acute Ischemic Stroke
06/23
06/23
ENVISION, NCT05310071 / 2022-001671-14: A Study to Verify the Clinical Benefit of Aducanumab in Participants With Early Alzheimer's Disease

Terminated
3
1027
Europe, Canada, Japan, US, RoW
Aducanumab, BIIB037, Aducanumab-avwa, Aduhelm, Placebo
Biogen, Biogen Idec Research Limited
Alzheimer's Disease
08/24
08/24
NCT04649242 / 2020-003517-35: Randomized Study in Children and Adolescents With Migraine: Acute Treatment

Recruiting
3
2100
Europe, Canada, Japan, US, RoW
Rimegepant/BHV3000, Matching placebo
Pfizer
Pediatric Migraine
01/29
01/29
TRAILBLAZER-ALZ 5, NCT05508789: A Study of Donanemab (LY3002813) in Participants With Early Symptomatic Alzheimer's Disease

Recruiting
3
1500
Europe, RoW
Donanemab, (LY3002813), Placebo
Eli Lilly and Company
Alzheimer Disease, Dementia, Brain Diseases, Central Nervous System Diseases, Nervous System Diseases, Tauopathies, Neurodegenerative Diseases, Neurocognitive Disorders, Mental Disorders
04/27
04/27
NCT05686642: Efficacy and Safety of LT3001 on Treating the Acute Ischemic Stroke

Recruiting
2
300
RoW
LT3001 Drug:high dose, Placebo, LT3001 Drug:low dose
Shanghai Pharmaceuticals Holding Co., Ltd
Acute Ischemic Stroke
04/25
07/25
PROGRESS-AD, NCT06079190: Efficacy and Safety of GSK4527226 [AL101] in Participants With Early Alzheimer's Disease

Recruiting
2
282
Europe, Canada, US, RoW
GSK4527226, Placebo
GlaxoSmithKline, Alector Inc.
Alzheimer's Disease
12/26
02/29
NCT03648268: Using Transcranial Magnetic Stimulation (TMS) to Understand 'Negative' Symptoms of Schizophrenia

Completed
N/A
47
US
repetitive Transcranial Magnetic Stimulation (rTMS), iTBS
Beth Israel Deaconess Medical Center, Mclean Hospital, Harvard University
Schizophrenia, Negative Type; Schizophrenic, Schizo Affective Disorder
12/23
12/23
PARK 5-HT4, NCT05916625: Exploratory Study of the Expression of the Serotonergic 5-HT4 Receptor in Parkinson's Disease

Recruiting
N/A
35
Europe
neuropsychological assessment, biological sample, medical imagery
Hospices Civils de Lyon
Parkinson Disease
06/25
06/25
C-DIAMOND, NCT04952207: Effectiveness and Safety of Direct-Acting Antiviral Agents for the Treatment of Chronic Hepatitis C

Recruiting
N/A
300
RoW
Direct-acting antiviral agents, daclatasvir, asunaprevir, ombitasvir, paritaprevir, dasabuvir, sofosbuvir, velpatasvir, ledipasvir, elbasvir, grazoprevir, danoprevir, glecaprevir, pibrentasvir, voxilaprevir
Qing XIe, Gilead Sciences, Tigermed Consulting Co., Ltd
Hepatitis C, Chronic
07/21
08/21
Wang, Zishu
NCT03236649: The Phase III Study of Icaritin Versus Sorafenib in PD-L1 Positive Advanced Hepatocellular Carcinoma Subjects

Terminated
3
89
RoW
Icaritin, Sorafenib Tosylate Tablets
Beijing Shenogen Biomedical Co., Ltd, Cancer Institute and Hospital, Chinese Academy of Medical Sciences, Eastern Theater General Hospital,QinHuai District Medical Area, Peking University Cancer Hospital & Institute, Chinese PLA General Hospital, Beijing Hospital, General Hospital of Chinese Armed Police Forces, Guang'anmen Hospital of China Academy of Chinese Medical Sciences, Jinan Central Hospital, Linyi Cancer Hospital, The First Affiliated Hospital of Anhui Medical University, Anhui Provincial Hospital, The First Affiliated Hospital with Nanjing Medical University, The Affiliated Tumor Hospital of Nantong University, Nantong, Jiangsu Province, China, Nanfang Hospital of Southern Medical University, First People's Hospital of Foshan, Affiliated Cancer Hospital & Institute of Guangzhou Medical University, Tianjin Medical University Cancer Institute and Hospital, The Fourth Hospital of Hebei Medical University, Hunan Cancer Hospital, The First Hospital of Jilin University, 307 Hospital of PLA, Fudan University, Henan Cancer Hospital, Jilin Provincial Tumor Hospital, First Affiliated Hospital of Harbin Medical University, First Affiliated Hospital Bengbu Medical College, The First Affiliated Hospital of Soochow University, Tongji Hospital, Beijing YouAn Hospital
Hepatocellular Carcinoma (HCC)
02/22
02/22
NCT04603040: A Study to Evaluate the Efficacy and Safety of Toripalimab Injection in the Treatment of Recurrent or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma Who Have Failed at Least Two Prior Lines of Therapy and Are Positive Specific Markers

Recruiting
2
100
RoW
Toripalimab, Tuoyi
Shanghai Junshi Bioscience Co., Ltd.
Recurrent or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma Who Have Failed at Least Two Prior Lines of Therapy
12/22
03/23
NCT05315830: A Study of HER2 Tumor Vaccine in Patients With Her-2 Positive Gastric/GEJ Adenocarcinoma Esophagogastric

Recruiting
1
10
RoW
HER2 Tumor Vaccine, HER2 Tumor Vaccine+ Standard of Care chemotherapy
First Affiliated Hospital Bengbu Medical College
Adenocarcinoma - GEJ, Adenocarcinoma of the Stomach
03/23
03/24
NCT05088070: Clinical Study of SPH3348 Tablets, a C-Met Inhibitor, in Patients with Advanced Solid Tumors

Completed
1
40
NA
SPH 3348
Shanghai Pharmaceuticals Holding Co., Ltd
Solid Tumor
07/23
07/23

Download Options